Dominique Larrey

5PUBLICATIONS
22CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Characterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 17, 2026
Correction: Liver Safety of the Dual Neurokinin‑1/‑3 Receptor Antagonist Elinzanetant.

|Mar 18, 2026
Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant.

James H Lewis, Raúl J Andrade, Dominique Larrey

|Dec 04, 2025
Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the New Era of Expanding Non-oncology Indications: Literature Review and Expert Consensus.

Anna Fettiplace, Arie Regev, Alexandre Kiazand

|Jan 08, 2023
Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype Susceptibility.

Lucy Meunier, Dominique Larrey

|Dec 08, 2022
An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir-grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study).

Jean-Pierre Bronowicki, Patrick Miailhes, Bertrand Hanslik

Pageof 1

Frequent Collaborators

3 joint publications

James H Lewis

2 joint publications

Richard A Anderson

2 joint publications

Esther Groettrup-Wolfers

2 joint publications

Yves Horsmans